Introducing a “same day referral” program for post-coital IUD insertion in Ontario: A mixed-methods study with pharmacists

Contenu principal de l'article

Andreanne Chaumont
Angel M. Foster

Résumé

Objectives:

Post-coital insertion of the Copper-T intrauterine device (IUD) is the most effective method of emergency contraception (EC). However, few women use this method of pregnancy prevention in Canada. Our study aimed to explore Ontario pharmacists’ knowledge of the IUD as EC and interest in a hypothetical “same day referral” program that would provide women seeking progestin-only EC with information about and a timely referral for post-coital IUD insertion.

Methods:

We received 198 mailed surveys from representatives of Ontario pharmacies and conducted 17 in-depth interviews with a subset of respondents in 2015. We analyzed the survey data using descriptive statistics and interviews for content and themes using both deductive and inductive techniques.

Results:

Our results suggest that Ontario pharmacists underestimate the efficacy of the IUD as EC and lack awareness of the protocols for use. Survey respondents and interviewees expressed support for a “same day referral” program in Ontario and believe more effective methods of EC should be easily accessible. Interviewees discussed current barriers to the use of IUDs as EC, including the up-front costs associated with insertion and a general lack of awareness about EC among health professionals and communities.

Discussion:

There is a significant need for continuing education on the full range of EC methods among pharmacists. Considerable enthusiasm exists for undertaking efforts to expand access to more effective EC methods. Developing a pilot project to facilitate timely referrals for post-coital IUD insertion appears warranted.

Résumé

Objectifs : L’insertion postcoïtale d’un dispositif intra-utérin (DIU) au cuivre est la méthode la plus efficace de contraception d’urgence (CU). Toutefois, peu de femmes au Canada utilisent cette méthode de prévention de la grossesse. Notre étude visait à explorer les connaissances des pharmacien(ne)s ontarien(ne)s sur le DIU utilisé comme CU, ainsi que leur intérêt pour un programme hypothéque d’orienta on du même jour, qui fournirait en temps opportun de l’information et une insertion postcoïtale d’un DUI aux femmes désirant une CU à progestatif seul.

Méthodes : Nous avons reçu 198 sondages par la poste de la part de représentants de pharmacies ontariennes, et avons mené 17 entrevues détaillées avec un sous-ensemble des répondants en 2015. Nous avons analysé les données de l’enquête à l’aide de statisques descriptives, ainsi que le contenu et les thèmes des entrevues au moyen de méthodes déductives et inductives.

Résultats : Nos résultats indiquent que les pharmacien(ne)s de l’Ontario sous-estiment la capcacité du DIU utilisé comme CU et ne connaissent pas les protocoles nécessaires. Les répondants à l’enquête et les sujets interrogés ont exprimé leur soutien au programme d’orientation du jour même en Ontario et croient que des méthodes plus efficaces de CU devraient être facilement accessibles. Les personnes interrogées ont discuté des obstacles actuels à l’utiisation du DIU utilisé comme CU, incluant les coûts initiaux associés à l’insertion, et le manque général de connaissances sur la CU parmi les professionnels de la santé et les communautés.

Discussion : Il existe un besoin important de formations professionnelles continues pour les pharmacien(ne)s sur la gamme complète de CU. Plusieurs démontrent un enthousiasme considérable quant au déploiement d’efforts pour améliorer l’accès à des méthodes plus efficaces de CU. Il semble justifié d’instaurer un projet pilote qui faciliterait l’orientation pour la pose postcoïtale d’un DIU, et ce, en temps opportun. 

 

Renseignements sur l'article

Rubrique
Original Research

Références

1. Fisher W, Boroditsky R, Morris B. The 2002 Canadian contraception study: part 1. J Obstet and Gynaecol Can. 2004;26(6):580-90.

2. Peipert JF, Zhao Q, Allsworth JE, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117:1105-13.

3. Trussell J. Emergency contraception: hopes and realities. Chapter in Emergency contraception: the story of a global reproductive health technology AM Foster & LL Wynn (Eds). New York, NY: Palgrave Macmillan; 2012. 20-35 p.

4. Black A, Guilbert E. Canadian contraception consensus: part 1. J Obstet and Gynaecol Can. 2015;37(10):936-8.

5. Cleland K, Zhu H, Goldstuck N, Cheng L, Trussell J. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod. 2012; 27(7):1994-2000.

6. Sivin I. Utility and drawbacks of continuous use of copper T IUC for 20 years. Contraception. 2007;74(6):1102-7.

7. Dunn S, Anderson GM, Bierman AS. Temporal and regional trends in IUD insertion: a population-based study in Ontario, Canada. Contraception. 2009;80(5):469-73.

8. Wier E. Preventing pregnancy: a fresh look at the IUD. CMAJ. 2003;169(6):585.

9. Goertzen J. Learning procedural skills in family medicine: comparison of rural and urban programs. Can Fam Physician. 2006;52:622-3.

10. Soon J, Levine M, Osmond, B Ensom M, Fielding D. Effects of making emergency contraception available without a physician’s prescription: a population-based study. CMAJ. 2005;172(7):878-83.

11. Dunn S, Brown TE, Alldred J. Availability of emergency contraception after its deregulation from prescription-only status: a survey of Ontario pharmacies. CMAJ. 2008;178(4):423-4.

12. Eggertson L, Sibbald B. Privacy issues raised over Plan B: women asked for names, addresses, sexual history. CMAJ. 2005;173(12):1435-6.

13. Erdman J. Canada: competing frames of access and authority. In A Foster & L Wynn (eds.), Emergency contraception: the story of a global reproductive health technology. New York: Palgrave Macmillan; 2012. 57-78 p.

14. Wynn L, Erdman J, Foster A, Trussell J. Harm reduction or women’s rights? Debating access to emergency contraceptive pills in Canada and the United States. Stud Fam Plann. 2007;38(4):253-67.

15. Health Canada. Emergency contraceptive pills to carry warnings for reduced effectiveness in women over a certain body weight [Internet]. Government of Canada; 2014 [cited 2017 March 25]. Available from: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/38701a-eng.php.

16. Health Canada. Health product info watch - product monograph and medical device instructions for use updates [Internet]. November 2015 [cited: 2016 March 28]. Available from: www.hcsc.gc.ca/dhpmps/medeff/bulletin/hpiw-ivps_2015-11-eng.php#j.

17. Wiebe E, Soon J, Trouton K. Increasing the use of copper intrauterine devices (IUDs) for emergency contraception. Presentation at the 2015 North American Forum on Family Planning, Chicago, IL: Nov 13-16, 2015.

18. Options for Sexual Health. EC-IUD rapid access network [Internet]. Options for Sexual Health; 2017 [cited 2017 March 25]. Available from: http://www.emergencyiud.com/.

19. Chaumont A, Foster A. The not so over-the-counter status of emergency contraception in Ontario: a mixed-methods study with pharmacists. FACETS. 2017;2:1-11.

20. Black A, Guilbert E. Canadian contraception consensus (part 1 of 4). J Obstet and Gynaecol Can. 2015;37(10):936-8.

21. Luchowski AT, Anderson BL, Power ML, Rglan GB, Espey E, Schulkin J. Obstetrician-gynecologists and contraception: practice and opinions about the use of IUDs in nulliparous women, adolescents and other patient populations. Contraception. 2014;89(6):572-7.

22. Cristobal I, Neyro JL, Lete I. The new LNG-releasing IUS: a new opportunity to reduce the burden of unintended pregnancy. Eur J Obstet Gynecol Reprod Biol. 2015;190:58-64.

23. Hall KS, Ela E, Zochowski MZ, et al. “I don’t know enough to feel comfortable using them:” women’s knowledge of and perceived barriers to long-acting reversible contraceptives on a college campus. Contraception. 2016; 93(6):556-64.

24. Haper CC, Speidel JJ, Drey EA, Trussell J, Blunn M, Darney PD. Copper intraunterine device of emergency contraception: clinical practice among contraceptive providers. Obstet Gynecol. 2012;199(2 Pt 1):200-6.

25. Batur P, Cleland K, McNamara M, Wu J, Pickle S, EC Survey Group. Emergency contraception: a multispecialty survey of clinician knowledge and practices. Contraception. 201693(2):145-52.

26. Broecker J, Jurich J, Fuchs R. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis. Contraception. 2016;93(3):266-72.

27. Turok DK, Gurtcheff SE, Handley E, et al. A survey of women obtaining emergency contraception: are they interested in using the copper IUD?. Contraception. 2011;83(5):441-6.